Compare PATH & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PATH | TFX |
|---|---|---|
| Founded | 2005 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 5.8B |
| IPO Year | 2021 | 1994 |
| Metric | PATH | TFX |
|---|---|---|
| Price | $10.27 | $127.00 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 17 | 8 |
| Target Price | $14.41 | ★ $138.75 |
| AVG Volume (30 Days) | ★ 45.2M | 536.3K |
| Earning Date | 05-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.02% |
| EPS Growth | ★ 500.00 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | $1,610,572,000.00 | ★ $1,992,713,000.00 |
| Revenue This Year | $11.82 | $15.97 |
| Revenue Next Year | $8.50 | $5.15 |
| P/E Ratio | $257.88 | ★ N/A |
| Revenue Growth | ★ 12.65 | N/A |
| 52 Week Low | $9.20 | $100.18 |
| 52 Week High | $19.84 | $139.67 |
| Indicator | PATH | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 42.16 | 46.17 |
| Support Level | $9.52 | $124.49 |
| Resistance Level | $11.26 | $135.21 |
| Average True Range (ATR) | 0.69 | 3.76 |
| MACD | -0.15 | -0.70 |
| Stochastic Oscillator | 11.75 | 23.49 |
UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform. The platform leverages a range of automation technologies, including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries, including claims processing, employee onboarding, invoice-to-cash, loan applications, and customer service. The company works in the Americas, Europe, the Middle East, and Africa, and Asia-Pacific, with the maximum revenue from the America.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.